LaFortune Cancer Center at St. John Medical Center

Tulsa, Oklahoma 74104

0 studies enrolling now · 10 studies all time

What they study most

Anal Cancer, Breast Adenocarcinoma, Breast Cancer, Chemotherapeutic Agent Toxicity, Colorectal Cancer, DS Stage I Plasma Cell Myeloma, DS Stage II Plasma Cell Myeloma, Dermatologic Complications, Drug/Agent Toxicity by Tissue/Organ, Lymphoma, Metastatic Malignant Neoplasm to the Bone, Musculoskeletal Complication

Studies at this site

• Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma — Completed
• Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy — Completed
• Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer — Completed
• Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement — Completed
• Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy — Completed
• Comparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast Cancer — Completed
• Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ — Completed
• S0000 Selenium and Vitamin E in Preventing Prostate Cancer — Completed
• Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal Cancer — Completed
• Sildenafil in Treating Erectile Dysfunction in Patients With Prostate Cancer — Completed